Key result
Metabolic syndrome linked to accelerated myocardial remodeling and worse prognosis in chronic HF.
Why the study?
Patients with chronic heart failure associated with metabolic syndrome continue to experience poorer functional capacity, higher hospitalization rates, and unfavorable prognosis despite pharmacological advances.
Comprehensive correction of metabolic disturbances is highlighted as an important component of contemporary management for patients with chronic heart failure and metabolic syndrome.
Answers are grounded in this paper and cite their sources.
May warrant integrated metabolic management in HF; leaves open optimal strategies for prospective trials.
Metabolic syndrome (MetS) is recognized as one of the most important contributors to cardiovascular morbidity and mortality worldwide. The coexistence of abdominal obesity, insulin resistance, arterial hypertension, dyslipidemia, and chronic low-grade inflammation substantially accelerates myocardial remodeling and promotes the progression of chronic heart failure (CHF). Despite remarkable advances in pharmacological management, patients with CHF associated with MetS continue to demonstrate poorer functional capacity, increased inflammatory activity, higher hospitalization rates, and unfavorable long-term prognosis. Comprehensive correction of metabolic disturbances has therefore become an important component of contemporary heart failure management.
No takes yet. Share an insight, caveat, or question.
S et al. (2026) conducted a review in Chronic heart failure and metabolic syndrome. Metabolic syndrome accelerates myocardial remodeling and worsens prognosis in patients with chronic heart failure, necessitating comprehensive correction of metabolic disturbances.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: